Detalhe da pesquisa
1.
Apatinib plus 5-fluorouracil as a third or subsequent-line treatment option for metastatic colorectal cancer: a phase-II, single-arm, prospective study.
Ann Transl Med
; 10(2): 100, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35282086